Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label randomized multicenter phase II study of CreaVax-HCC (autologous mature dendritic cells) in hepatocellular carcinoma after surgical or non-surgical therapy
KCT0000008Phase 2Completed
- Sponsor
- Korea Health Industry Development Institute
- Start
- Jun 2010
- Modality
- Dendritic Cell Vaccines → Immune Effector Cells → Other Cell Types → Cell Therapies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of CreaVax-HCC in hepatocellular carcinoma (HCC), sponsored by Korea Health Industry Development Institute. Started Jun 2010; status: completed.
02
Drugs
CreaVax-HCC
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on KCT0000008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000008.